Emerging trends in contract research industry in India

Contemporary Clinical Trials

Volumn 31, Issue 5, 2010, Pages 419-422

  Drabu, Sushma ^a   Gupta, Alka ^a   Bhadauria, Anupama ^a  

^a GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

Author keywords

Audit; Clinical trial; Contract research Organizations (CROs); Industry; Pharmacovigilance

Indexed keywords

CLINICAL RESEARCH; DRUG INDUSTRY; DRUG SURVEILLANCE PROGRAM; GOVERNMENT; HEALTH CARE PERSONNEL; INDIA; INVESTMENT; MARKET; ORGANIZATION; REVIEW;

AWARENESS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CONTRACTS; DRUG INDUSTRY; DRUG TOXICITY; HUMANS; INDIA; INTERNATIONAL COOPERATION; OUTSOURCED SERVICES;

EID: 77957750242     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.06.008     Document Type: Review

References (28)

1. http://www.nhs.uk/Conditions/Clinical-trials/Pages/Definition.aspx.
2. Sarin Dr. Kumud. Clinical Trials: Overview & Opportunities. http://www.assocham.org.
3. Contract research organization; http://www.absoluteastronomy.com.
4. http://en.wikipedia.org/wiki/Drug_development.
5. Datta PT, Jyothi. Clinical trial to fall short of billion-dollar projection. http://www.blonnet.com/2008/10/14/stories/2008101450880200.htm.
6. The Top 10 Contract Research Organizations: Positioning, Performance and SWOT Analyses http://www.researchandmarkets.com.
7. Indian Pharma Enters the Global Arena; https://www.researchgate.net.
8. Rituparna M, Raghavendra M. Clinical trials in India. http://www.sciencedirect.com.
9. Sehgal R. Outsourcing clinical trials to India - opportunities and challenges. The Pharmacol Rev 2009, 29-30.
10. Gangilt J., Gautam S., Kumar, Rajesh R., Thunga G., Pandey S. Clinical research opportunities in India: beyond the future. The Pharmacol Buzz August 2009, 6-7.
11. Clinical Trials: Growing Opportunities for India; http://www.pharmainfo.net.
12. Contract research on the rise, http://www.TheScientist.com.
13. Clinical trial segment poised to touch $1.5 bn by 2010: McKinsey report. http://www.indianexpress.com.
14. Patel R., Patel M. Quality audit: a tool to review quality system. The Pharmacol Rev May 2009, 127-129.
15. Seoane P. Use and limitations of checklists, other strategies for audits and inspections. Qual Assur J 2001, 5:133-136.
16. Joseph J. Entering the contract research industry in India. http://www.researchgate.net.
17. Udupa N., Sreedhar D., Janodia M.D., Ligade V.S., Pise A. Clinical trials in India: current scenario and future outlook. The Pharma Review May 2009, 36-37.
18. http://www.ctri.in/Clinicaltrials/do/login1?action=toFAQ#1a.
19. Tiner R. Transparency is the key to clinical trial agreement. DDT 2005, 10(9).
20. Murti Y., Verma P., Pathak D. Awareness of the risk factors in volunteers of clinical trials. The Pharma Review 2009, 68.
21. http://www.pharmacovigilance.co.in/nppIndia.html.
22. http://www.cdsco.nic.in/html/tor3.htm.
23. Adithan C. National pharmacovigilance programme. Indian J Pharmacol 2005, 37(6):347.
24. Health Ministry to double ADR monitoring centres in country soon; http://www.pharmabiz.com.
25. Pharmacovigilance and Clinical Trials. The Pharma Review 2009; 62-67.
26. Biswas P., Biswas A.K. Setting standards for proactive pharmacovigilance in India. The way forward 2007, 39(3):124-128.
27. Sawant P, Roychowdhury. What are the three main challenges faced by the Indian clinical market? http://www.pharmabioworld.com.
28. Nundy S., Gulhati C.M. A new colonialism? Conducting clinical trials in India. N Eng J Med 2005, 352(16):1633-1636.